Accuray (ARAY) Return on Capital Employed (2011 - 2026)
Accuray (ARAY) reported Return on Capital Employed of 23.7% for Q1 2026, down 5480.0% on a YoY basis from 0.44% in Q1 2025, and down 155.25% quarter-over-quarter from 9.29% in Q4 2025.
Accuray (ARAY) Return on Capital Employed (2011 - 2026) Analysis & Trends
Accuray has reported Return on Capital Employed for 16 years, with the latest figure at 23.7% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 5480.0% year-over-year to 23.7%; the trailing twelve-month figure through Mar 2026 stood at 23.7% (down 5480.0% YoY), and the FY2025 full-year result was 0.17%, down 356.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 23.7%, down from 9.29% in the prior quarter.
- The five-year high for Return on Capital Employed was 56.55% in Q3 2023, with the low at 23.7% in Q1 2026.
- Historically, Return on Capital Employed has averaged 13.41% across 5 years, with a median of 20.29% in 2022.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 9565 bps — and 2023, when it surged 3256 bps.
- Accuray's Return on Capital Employed stood at 20.29% in 2022, then climbed by 12 bps to 22.66% in 2023, then slumped by 66 bps to 7.62% in 2024, then sank by 222 bps to 9.29% in 2025, then sank by 155 bps to 23.7% in 2026.
- The last three Return on Capital Employed figures came in at 23.7% (Q1 2026), 9.29% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Accuray | 41,092.55 | -38.49 Mn | 25.29 Mn | -23.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.70% |
| Dec 31, 2025 | -9.29% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 6.71% |
| Mar 31, 2025 | 31.10% |
| Dec 31, 2024 | 7.62% |
| Sep 30, 2024 | -19.36% |
| Jun 30, 2024 | 2.20% |
| Mar 31, 2024 | -1.29% |
| Dec 31, 2023 | 22.66% |
| Sep 30, 2023 | 56.55% |
| Jun 30, 2023 | 21.87% |
| Mar 31, 2023 | 21.50% |
| Dec 31, 2022 | 20.29% |
| Sep 30, 2022 | 23.99% |
| Jun 30, 2022 | 36.00% |
| Mar 31, 2022 | 31.15% |
| Dec 31, 2021 | 42.29% |
| Sep 30, 2021 | 119.63% |
| Jun 30, 2021 | 76.49% |